C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01)
Patent
CA 2642922
The present invention relates to a class of melanocortin MCR4 agonists of general formula (I), wherein the variables and substituents are as defined herein and especially to selective MCR4 agonist compounds, to their use in medicine, particularly in the treatment of sexual dysfunction and obesity, to intermediates useful in their synthesis and to compositions containing them.
La présente invention concerne une classe d'agonistes du MCR4 de formule générale (I), les variables et substituants étant tels que définis dans la présente invention, et plus spécialement des composés agonistes de MCR4 sélectifs, leurs applications en médecine, en particulier dans le traitement des dysfonctionnements sexuels et de l'obésité, des intermédiaires pouvant être employés dans leur synthèse et des compositions les incluant.
Andrews Mark David
Brown Alan Daniel
Lansdell Mark Ian
Summerhill Nicholas William
Limited Pfizer
Torys Llp
LandOfFree
Melanocortin type 4 receptor agonist piperidinoylpyrrolidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanocortin type 4 receptor agonist piperidinoylpyrrolidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanocortin type 4 receptor agonist piperidinoylpyrrolidines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1964676